Having trouble accessing articles? Reset your cache.

Taspoglutide: Completed Phase III enrollment

Roche completed enrollment of 990 patients with Type II diabetes mellitus inadequately controlled with metformin plus sulphonylurea in the open-label,

Read the full 208 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE